Anne W. Beaven, MD

Department / Division:
Medicine / Medical Oncology

Address:
DUMC 3872
Durham, NC 27710

Appointment Telephone:
(919) 684-8964

Office Telephone:
(919) 684-8964

Fax Telephone:
(919) 684-5325

• M.D., University of North Carolina at Chapel Hill, 2000

• Internal Medicine, University of North Carolina at Chapel Hill, 2000-2003

• Hematology/Oncology, University of North Carolina at Chapel Hill, 2004-2007

Clinical Interests:
Treatment of hematologic malignancies with a particular interest in clinical trials in lymphoma

Research Interests:
My particular area of research interest is clinical trails for patients with lymphoma.

Representative Publications:
Beaven AW, Shea TC. Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplant. Drugs Today (Barc). 2007 Jul;43(7):461-73. (2007) Abstract

Beaven AW, Goldberg RM. Adjuvant therapy for colorectal cancer: yesterday, today, and tomorrow. Oncology (Williston Park). 2006 Apr;20(5):461-9; discussion 469-70, 473-5. (2006) Abstract

Beaven AW, Shea TC. Palifermin: a keratinocyte growth factor that reduces oral mucositis after stem cell transplant for haematological malignancies. Expert Opin Pharmacother. 2006 Nov;7(16):2287-99. (2006) Abstract

Beaven AW, Shea TC. The effect of palifermin on chemotherapy and radiation therapy induced mucositis: A review of the current literature.  Supportive Cancer Therapy, 4(4):188-197, 2007. (2007)